1. Singapore Stocks

  2. •

    Technology

  3. •

    Hardware, Equipment & Parts
Venture Corporation Limited

Venture Corporation Limited

VEMLF
Venture Corporation LimitedUS flagOther OTC
13.99
USD
- -
- -
4.02BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.47
8.97
9.63
10.36
14.2
12.12
12.6
10.41
10.7
13.28
10.4
9.43
- -
12.6
Basic EPS, GAAP
0.48
0.28
0.56
0.65
1.32
1.29
1.26
1.03
1.07
1.27
0.93
0.85
- -
1.26
Free Cash Flow per Basic Share
0.25
0.4
0.79
0.71
1.46
0.68
0.67
1.47
0.31
0.81
1.63
1.61
- -
0.67
Dividend per Share
0.5
0.5
0.5
0.5
0.5
0.8
0.7
0.75
0.75
0.75
0.75
0.75
- -
0.7
Book Value per Share
7.54
7.17
7.38
7.05
7.93
8.41
8.97
9.27
9.58
10.1
10.27
10.33
- -
8.97
Tangible Book Value per Share
4.11
4.08
4.48
4.77
5.42
5.96
6.45
6.74
7.16
7.57
7.55
7.78
- -
6.45
Basic Weighted Avg Shares
275
275
276
277
282
287
288
289
290
291
291
290
- -
288
Sales/Revenue/Turnover
2,329
2,465
2,656
2,874
4,004
3,484
3,633
3,012
3,107
3,863
3,024
2,734
2,532
3,633
Operating Margin (%)
5.56
6.01
6.37
7.05
10.63
12.08
11.11
11.08
11.17
11.24
9.9
9.53
9.61
11.11
Depreciation Expense
46
44
46
46
31
31
39
42
37
33
31
33
34
39
Net Income, GAAP
131
76
154
181
373
370
363
297
312
370
270
245
227
363
Effective Tax Rate (%)
6.43
17.96
15.21
16.29
16.01
14.52
13.49
13.25
13.14
17.55
18.15
19.84
19.96
13.49
Profit Margin (%)
5.63
3.08
5.8
6.29
9.31
10.62
10
9.87
10.04
9.57
8.93
8.96
8.96
10
Working Capital
878
882
1,017
1,080
1,302
1,456
1,590
1,687
1,830
1,940
1,909
1,941
1,850
1,590
LT Debt
- -
- -
26
- -
- -
- -
17
11
5
13
19
18
11
17
Total Equity
1,829
1,801
1,896
1,963
2,168
2,352
2,499
2,589
2,719
2,843
2,838
2,894
2,798
2,499
Return on Invested Capital (%)
6.1
6.11
7.13
8.23
16.6
15.57
14.11
11.12
11.17
12.61
8.41
7.1
6.68
14.11
Return on Capital (%)
5.91
3.51
7.17
8.59
17.31
15.82
14.42
11.19
11.35
12.83
9.02
8.11
7.53
14.42
Return on Common Equity (%)
6.33
3.76
7.68
9.05
17.8
15.91
14.52
11.29
11.43
12.93
9.12
8.19
7.61
14.52

Capital Structure

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
ST Debt
7
12
12
LT Borrowings
- -
- -
- -
LT Finance Leases
9
19
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
288
288
288
Market Capitalization
3,245
3,315
3,392

Working Capital

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
Total Current Assets
2,272
2,348
2,345
Cash, Cash Equivalents & STI
762
804
714
Accounts Receivable, Net
692
726
899
Inventories
750
761
706
Total Current Liabilities
792
837
755
Payables & Accruals
- -
- -
- -
ST Debt
7
12
12
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.04%
1.61%
-3.33%
Free Cash Flow
29.3%
25.79%
-52.02%
Net Income, GAAP
8.28%
-4.04%
-7.38%
Sales/Revenue/Turnover
1.05%
-2.24%
-7.39%
Total Cash Common Dividend
6.67%
1.22%
5.8%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
3,024
2024
- -
- -
- -
- -
2,734
2025
- -
- -
- -
- -
2,532

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.93
2024
- -
- -
- -
- -
0.85
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.75
2024
- -
- -
- -
- -
0.75
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Chee Kheong Wong
Full Time Employees
9,987
Sector
Technology
Industry
Hardware, Equipment & Parts
Address
5006 Ang Mo Kio Avenue 5 Singapore CE Singapore 569873
IPO Date
Feb 27, 2012
Website
venture.com.sg
Similar Companies
Public Joint-Stock Company Donskoy Plant of Radiocomponents (DZRD.ME)
Levenhuk Inc. (LVHK.ME)
Cyient DLM Limited (CYIENTDLM.BO)
Unitech Printed Circuit Board Corp. (2367.TW)
Chiyoda Integre Co.,Ltd. (6915.T)
RoboGroup T.E.K. Ltd. (ROBO.TA)
Business
Venture Corporation Limited (SGX: V03; OTC: VEMLF), founded in 1989 through the merger of three contract manufacturing firms and headquartered at TECHplace II in Singapore, serves as a leading global provider of technology services, products and solutions, with differentiated capabilities spanning research and development, product industrialisation, advanced manufacturing, supply chain management and product lifecycle services across diverse domains including life science and genomics, molecular diagnostics, medical devices and equipment, healthcare and wellness technology, lifestyle consumer technology, health improvement products, instrumentation, test and measurement technology, networking and communications, fintech, advanced industrials, computing, printing and imaging technology; the company operates over 30 subsidiaries through global clusters of excellence in Southeast Asia (Singapore, Malaysia including new 442,000 square-foot facility in Batu Kawan, Penang), Northeast Asia (China facilities in Shanghai, Suzhou and Jiangsu), America (Milpitas, California) and Europe (Barcelona, Spain), employing more than 12,000 people and managing a portfolio exceeding 5,000 products for over 100 customers including Fortune 500 corporations, with wholly-owned subsidiaries VIPColor Technologies Pte Ltd offering on-demand color label printing solutions and Advanced Products Corporation Pte Ltd providing embedded systems. In recent developments, Venture completed construction of its expansive Batu Kawan manufacturing facility to bolster capacity amid China+1 supply chain shifts, reported FY2024 revenue of S$2.74 billion (down 9.6% year-on-year) with net profit of S$245 million amid softer demand particularly in lifestyle consumer technology due to enhanced product reliability extending replacement cycles, achieved Q1 FY2025 net profit margin improvement to 9.1% through cost efficiencies and higher-value solutions despite 7.5% revenue decline to S$617 million, generated strong operating cash flows including S$190 million in 9M FY2025 while maintaining a net cash position of S$1.26 billion with zero borrowings as of mid-2025 to support dividends (proposed 75 S-cents for FY2024), share buybacks (completed repurchase of 2.53 million shares equating to 0.87% of issued capital) and investments in R&D and productivity enhancements, and continues securing new business wins in networking, communications, data centres, semiconductor tools and life sciences through strategic customer partnerships such as with Illumina for genome sequencing advancements and laboratory instrument firms for next-generation mass spectrometry.